Synthesis and pharmacological evaluation of new pyrazolidine-3, 5-diones as AT1 angiotensin II receptor antagonists
B Le Bourdonnec, E Meulon, S Yous…
Index: Le Bourdonnec, Bertrand; Meulon, Emmanuelle; Yous, Said; Goossens, Jean-Francois; Houssin, Raymond; Henichart, Jean-Pierre Journal of Medicinal Chemistry, 2000 , vol. 43, # 14 p. 2685 - 2697
Full Text: HTML
Citation Number: 54
Abstract
On the basis of the structure of the non-peptide receptor antagonist irbesartan, a new series of AT1 ligands was designed. In these compounds the central imidazolone nucleus of irbesartan was replaced by a pyrazolidine-3, 5-dione structure. The key intermediate N- alkylpyrazolidine-3, 5-diones were synthesized according to a new and general method. The most active compounds possess a spirocyclopentane ring at position 4, a linear butyl ...
Related Articles:
[Kende,A.S.; Fludzinski,P.; Hill,J.H. Journal of the American Chemical Society, 1984 , vol. 106, p. 3551]
[Hedenstroem, Erik; Andersson, Fredrik Journal of chemical ecology, 2002 , vol. 28, # 6 p. 1237 - 1254]